MedPath

Biorasi, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

Phase 3
Completed
Conditions
Papulopustular Rosacea
Erythematotelangiectatic Rosacea
Interventions
Drug: Placebo Gel
First Posted Date
2015-03-20
Last Posted Date
2020-09-03
Lead Sponsor
bioRASI, LLC
Target Recruit Count
963
Registration Number
NCT02393937
© Copyright 2025. All Rights Reserved by MedPath